| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Morningside Venture Investments Ltd is a 10% Owner at Apellis Pharmaceuticals, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $615.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2020 | KZR Kezar Life Sciences, Inc. | 10% Owner | Buy | 3,800,000 | $2.60 | $9,880,000.00 | +164.6% | |
| Jan 13, 2020 | APLS Apellis Pharmaceuticals, Inc. | 10% Owner | Buy | 540,540 | $37.00 | $19,999,980.00 | +4.5% | |
| Mar 11, 2019 | APLS Apellis Pharmaceuticals, Inc. | 10% Owner | Buy | 441,176 | $17.00 | $7,499,992.00 | +3.8% | |
| Jun 25, 2018 | KZR Kezar Life Sciences, Inc. | 10% Owner | Buy | 250,000 | $15.00 | $3,750,000.00 | +12.1% |